Cash from Investing (TTM) Chart

View Cash from Investing (TTM) for ANGO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Investing (TTM) Chart
Start Trial

Historical Cash from Investing (TTM) Data

View and export this data back to 2005. Start Trial.
Date Value
February 28, 2026 -7.302M
November 30, 2025 -8.984M
August 31, 2025 -9.324M
May 31, 2025 -10.18M
February 28, 2025 -9.891M
November 30, 2024 22.70M
August 31, 2024 22.87M
May 31, 2024 123.72M
February 29, 2024 124.52M
November 30, 2023 92.98M
August 31, 2023 92.27M
May 31, 2023 -9.746M
February 28, 2023 -11.99M
November 30, 2022 -12.44M
August 31, 2022 -13.79M
May 31, 2022 -19.31M
February 28, 2022 -24.68M
November 30, 2021 -23.47M
August 31, 2021 -20.98M
May 31, 2021 -13.71M
February 28, 2021 -6.046M
November 30, 2020 -16.41M
August 31, 2020 -63.63M
May 31, 2020 -63.34M
February 29, 2020 106.56M
Date Value
November 30, 2019 118.77M
August 31, 2019 118.70M
May 31, 2019 82.55M
February 28, 2019 -86.62M
November 30, 2018 -88.77M
August 31, 2018 -40.84M
May 31, 2018 -3.656M
February 28, 2018 -3.655M
November 30, 2017 -2.377M
August 31, 2017 -2.571M
May 31, 2017 -2.551M
February 28, 2017 -5.489M
November 30, 2016 -7.822M
August 31, 2016 -7.307M
May 31, 2016 -7.569M
February 29, 2016 -5.139M
November 30, 2015 -6.663M
August 31, 2015 -8.778M
May 31, 2015 -13.29M
February 28, 2015 -15.47M
November 30, 2014 -13.01M
August 31, 2014 -14.94M
May 31, 2014 -16.45M
February 28, 2014 -17.44M
November 30, 2013 -27.01M

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Range, Past 5 Years

View Cash from Investing (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Investing (TTM) Benchmarks

View Cash from Investing (TTM) Benchmarks
Start Trial
Globus Medical, Inc. -669.07M
Abbott Laboratories -22.28B
Alphatec Holdings, Inc. -61.69M
AtriCure, Inc. -16.72M
Baxter International, Inc. -557.00M